Regulus Therapeutics (RGLS) Institutional Ownership $1.31 +0.04 (+3.15%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.34 +0.02 (+1.91%) As of 02/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Regulus Therapeutics (NASDAQ:RGLS)CurrentInstitutional OwnershipPercentage92.38%Number ofInstitutional Buyers(last 12 months)23TotalInstitutional Inflows(last 12 months)$72.62MNumber ofInstitutional Sellers(last 12 months)9TotalInstitutional Outflows(last 12 months)$17.32M Get RGLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Regulus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RGLS Institutional Buying and Selling by Quarter Regulus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Velan Capital Investment Management LP70,000$111K0.1%N/A0.107% 2/17/2025 Octagon Capital Advisors LP4,848,802$7.66M1.3%+13.7%7.403% 2/17/2025 Millennium Management LLC2,192,158$3.46M0.0%+69.7%3.347% 2/17/2025 DAFNA Capital Management LLC875,200$1.38M0.4%-2.2%1.336% 2/14/2025 RA Capital Management L.P.336,843$532K0.0%-56.1%0.514% 2/14/2025 Northern Trust Corp457,233$722K0.0%-8.1%0.698% 2/14/2025 Price T Rowe Associates Inc. MD29,597$47K0.0%-98.6%0.045% 2/13/2025 PEAK6 LLC60,000$95K0.0%N/A0.092% 2/13/2025 Barclays PLC96,247$152K0.0%+13.9%0.147% 2/13/2025 Renaissance Technologies LLC117,100$185K0.0%+20.5%0.179% Get the Latest News and Ratings for RGLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025 JPMorgan Chase & Co.190,457$301K0.0%+141.2%0.291% 2/6/2025 Victory Capital Management Inc.389,886$616K0.0%-2.3%0.595% 1/30/2025 Rhumbline Advisers59,531$94K0.0%-20.1%0.091% 12/26/2024 JPMorgan Chase & Co.78,972$124K0.0%+193.4%0.121% 11/19/2024 Barclays PLC84,477$132K0.0%+285.2%0.129% 11/16/2024 Geode Capital Management LLC1,280,567$2.01M0.0%-4.0%1.955% 11/15/2024 Barclays PLC84,477$132K0.0%+285.2%0.129% 11/15/2024 Jane Street Group LLC29,580$46K0.0%N/A0.045% 11/15/2024 State Street Corp1,000,998$1.57M0.0%+3.5%1.528% 11/15/2024 RA Capital Management L.P.766,834$1.20M0.0%-87.7%1.171% 11/15/2024 Point72 Asset Management L.P.893,762$1.40M0.0%N/A1.365% 11/14/2024 NEA Management Company LLC6,467,802$10.15M0.6%N/A9.875% 11/13/2024 FMR LLC328,157$515K0.0%-83.8%0.501% 11/13/2024 The Manufacturers Life Insurance Company129,700$204K0.0%N/A0.198% 11/5/2024 Victory Capital Management Inc.398,866$626K0.0%+10.4%0.609% 10/25/2024 Tyche Wealth Partners LLC106,089$167K0.0%+920.6%0.162% 10/11/2024 Creative Planning16,466$26K0.0%N/A0.025% 10/3/2024 SG Americas Securities LLC20,800$33K0.0%N/A0.032% 8/15/2024CVI Holdings LLC401,012$716K0.6%-71.5%0.613% 8/9/2024 Renaissance Technologies LLC118,100$211K0.0%+56.4%0.180% 8/5/2024 Victory Capital Management Inc.361,386$645K0.0%-1.8%0.552% 8/1/2024 Rhumbline Advisers76,472$136K0.0%N/A0.117% 7/26/2024 Bank of New York Mellon Corp197,193$352K0.0%N/A0.301% 5/29/2024 Opaleye Management Inc.170,308$490K0.1%N/A0.260% 5/17/2024 RA Capital Management L.P.6,250,000$18M0.2%N/A9.547% 5/15/2024 NEA Management Company LLC6,467,802$18.63M1.1%N/A9.879% 5/10/2024 Vanguard Group Inc.740,215$2.13M0.0%+158.4%1.131% 5/7/2024CVI Holdings LLC1,406,250$4.05M3.9%N/A2.148% 4/22/2024 Vivo Capital LLC5,000,000$14.40M1.1%N/A7.638% 2/5/2024 Victory Capital Management Inc.271,736$348K0.0%+16.5%1.344% We recommended Palantir in 2021, now we’re recommending this... (Ad)I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nice stream of income along the way.Our research indicates ONE AI stock is poised to benefit the most.11/13/2023 FMR LLC2,922,600$4.03M0.0%+32.4%14.454% 11/6/2023 Victory Capital Management Inc.233,207$322K0.0%+5.3%1.197% 8/14/2023 Prelude Capital Management LLC40,660$60K0.0%N/A0.209% 9/16/2022 Federated Hermes Inc.2,904,826$6.01M0.0%-90.0%19.850% 8/16/2022 DAFNA Capital Management LLC555,555$1.15M0.3%-90.0%3.797% 8/12/2022 Ikarian Capital LLC105,341$217K0.0%-91.8%0.722% 8/1/2022 Victory Capital Management Inc.221,506$459K0.0%-90.1%1.517% 7/19/2022 Commonwealth Equity Services LLC22,000$45K0.0%-83.2%0.151% 2/14/2022 DAFNA Capital Management LLC5,555,555$1.75M0.4%N/A6.382% 1/19/2022Asymmetry Capital Management L.P.2,731,044$860K0.5%+94.9%3.137% 11/15/2021 GSA Capital Partners LLP64,708$45K0.0%-68.6%0.074% 11/4/2021Asymmetry Capital Management L.P.1,401,491$968K0.6%-3.4%1.610% 10/29/2021 Commonwealth Equity Services LLC111,000$76K0.0%+38.8%0.128% 9/17/2021 Virtu Financial LLC79,193$64K0.0%N/A0.091% 8/27/2021Endurant Capital Management LP2,607,674$2.12M0.6%+9.7%2.996% 8/16/2021 State Street Corp176,494$144K0.0%N/A0.203% 8/13/2021 Geode Capital Management LLC589,196$479K0.0%+54.3%0.786% 8/13/2021 Vanguard Group Inc.3,095,237$2.52M0.0%-3.9%4.131% 8/12/2021 Lido Advisors LLC57,500$47K0.0%N/A0.077% 8/11/2021 Commonwealth Equity Services LLC80,000$65K0.0%+300.0%0.107% 8/10/2021Strategic Wealth Advisors Group LLC74,800$61K0.0%N/A0.100% 8/5/2021 GSA Capital Partners LLP206,265$168K0.0%N/A0.275% 7/31/2021Asymmetry Capital Management L.P.1,450,777$1.18M0.8%-26.9%1.936% 7/15/2021 Focused Wealth Management Inc200,000$163K0.0%+100.0%0.267% 5/19/2021 Squarepoint Ops LLC159,804$249K0.0%+1,477.7%0.213% 5/17/2021Endurant Capital Management LP2,376,557$3.71M1.0%N/A3.172% 5/17/2021 Ikarian Capital LLC1,245,989$1.94M0.1%N/A1.663% 5/17/2021 Atom Investors LP337,228$526K0.1%N/A0.450% 5/17/2021 Goldman Sachs Group Inc.18,049$28K0.0%-68.0%0.024% 5/12/2021 Northern Trust Corp117,654$184K0.0%+198.4%0.157% 5/12/2021 Geode Capital Management LLC381,892$595K0.0%+493.5%0.510% 5/11/2021 Acadian Asset Management LLC465,678$726K0.0%N/A0.622% 5/11/2021Asymmetry Capital Management L.P.1,985,472$3.10M1.6%N/A2.650% 5/4/2021 Commonwealth Equity Services LLC20,000$31K0.0%N/A0.027% 5/4/2021 Victory Capital Management Inc.2,227,199$3.47M0.0%+345.4%2.976% 5/3/2021 Focused Wealth Management Inc100,000$156K0.0%N/A0.134% 2/10/2021 Renaissance Technologies LLC449,200$606K0.0%N/A1.147% 2/5/2021BlackRock Inc.49,788$68K0.0%-23.2%0.127% 2/1/2021 Victory Capital Management Inc.499,989$675K0.0%N/A1.277% (Data available from 1/1/2016 forward) RGLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RGLS shares? During the previous two years, 29 institutional investors and hedge funds held shares of Regulus Therapeutics. The most heavily invested institutionals were Vivo Capital LLC ($14.40M), NEA Management Company LLC ($10.15M), Octagon Capital Advisors LP ($7.66M), Millennium Management LLC ($3.46M), Vanguard Group Inc. ($2.13M), Geode Capital Management LLC ($2.01M), and State Street Corp ($1.57M).Learn more on RGLS's institutional investors. What percentage of Regulus Therapeutics stock is owned by institutional investors? 92.38% of Regulus Therapeutics stock is owned by institutional investors. Learn more on RGLS's institutional investor holdings. Which institutional investors have been buying Regulus Therapeutics stock? Of the 25 institutional investors that purchased Regulus Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: NEA Management Company LLC ($12.94M), RA Capital Management L.P. ($6.25M), Vivo Capital LLC ($5M), CVI Holdings LLC ($1.41M), Millennium Management LLC ($900.74K), Point72 Asset Management L.P. ($893.76K), and FMR LLC ($716K). How much institutional buying is happening at Regulus Therapeutics? Institutional investors have bought a total of 30,532,235 shares in the last 24 months. This purchase volume represents approximately $73.73M in transactions. Which Regulus Therapeutics major shareholders have been selling company stock? Of the 9 institutional investors that sold Regulus Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RA Capital Management L.P. ($5.91M), Price T Rowe Associates Inc. MD ($2.12M), FMR LLC ($1.69M), CVI Holdings LLC ($1.01M), Geode Capital Management LLC ($52.94K), Northern Trust Corp ($40.07K), and DAFNA Capital Management LLC ($20K). How much institutional selling is happening at Regulus Therapeutics? Institutional investors have sold a total of 10,878,029 shares in the last 24 months. This volume of shares sold represents approximately $17.32M in transactions. Related Companies XOMA Major Shareholders Ironwood Pharmaceuticals Major Shareholders Vanda Pharmaceuticals Major Shareholders Verastem Major Shareholders Sangamo Therapeutics Major Shareholders Lexicon Pharmaceuticals Major Shareholders Achieve Life Sciences Major Shareholders Agenus Major Shareholders Fortress Biotech Major Shareholders Curis Major Shareholders This page (NASDAQ:RGLS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regulus Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regulus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RGLS Stock Alerts